These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3H)-ones as CFM-1 analogs: design, synthesis, QSAR analysis and anticancer activity. Alafeefy AM; Ashour AE; Prasad O; Sinha L; Pathak S; Alasmari FA; Rishi AK; Abdel-Aziz HA Eur J Med Chem; 2015 Mar; 92():191-201. PubMed ID: 25555142 [TBL] [Abstract][Full Text] [Related]
5. Palladium-catalyzed one-pot synthesis of quinazolinones via tert-butyl isocyanide insertion. Jiang X; Tang T; Wang JM; Chen Z; Zhu YM; Ji SJ J Org Chem; 2014 Jun; 79(11):5082-7. PubMed ID: 24810598 [TBL] [Abstract][Full Text] [Related]
6. Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation. Prasad MG; Lakshmi CV; Katari NK; Jonnalagadda SB; Pal M Anticancer Agents Med Chem; 2019; 19(16):2001-2009. PubMed ID: 31340741 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivatives. Kumar A; Rajput CS Eur J Med Chem; 2009 Jan; 44(1):83-90. PubMed ID: 18501478 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of quinazolin-4(3H)-ones via Pd(II)-catalyzed intramolecular C(sp2)-H carboxamidation of N-arylamidines. Ma B; Wang Y; Peng J; Zhu Q J Org Chem; 2011 Aug; 76(15):6362-6. PubMed ID: 21675775 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of quinazolin-4(3H)-ones via amidine N-arylation. Li B; Samp L; Sagal J; Hayward CM; Yang C; Zhang Z J Org Chem; 2013 Feb; 78(3):1273-7. PubMed ID: 23289853 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of 3-N-sugar-substituted-2, 4(1H,3H)-quinazolinedionesas anti-angiogenesis agents. Huang C; Meng X; Cui J; Li Z Molecules; 2009 Jul; 14(7):2447-57. PubMed ID: 19633615 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors. Al-Rashood ST; Hassan GS; El-Messery SM; Nagi MN; Habib EE; Al-Omary FAM; El-Subbagh HI Bioorg Med Chem Lett; 2014 Sep; 24(18):4557-4567. PubMed ID: 25139568 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of 1,4-substituted 1H-1,2,3-triazolo-quinazolin-4(3H)-ones by Huisgen 1,3-dipolar cycloaddition with PI3Kγ isoform selective activity. Srinivas M; Singh Pathania A; Mahajan P; Verma PK; Chobe SS; Malik FA; Nargotra A; Vishwakarma RA; Sawant SD Bioorg Med Chem Lett; 2018 Apr; 28(6):1005-1010. PubMed ID: 29486969 [TBL] [Abstract][Full Text] [Related]
13. Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones. Al-Omary FA; Abou-Zeid LA; Nagi MN; Habib el-SE; Abdel-Aziz AA; El-Azab AS; Abdel-Hamide SG; Al-Omar MA; Al-Obaid AM; El-Subbagh HI Bioorg Med Chem; 2010 Apr; 18(8):2849-63. PubMed ID: 20350811 [TBL] [Abstract][Full Text] [Related]
14. Catalyst-free synthesis of quinazolin-4-ones from (hetero)aryl-guanidines: application to the synthesis of pyrazolo[4,3-f]quinazolin-9-ones, a new family of DYRK1A inhibitors. Debray J; Bonte S; Lozach O; Meijer L; Demeunynck M Mol Divers; 2012 Nov; 16(4):659-67. PubMed ID: 22991074 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of 6-N-R-Tetrazolo[1,5-c]quinazolin-5(6H)-ones and Their Anticancer Activity. Antypenko O; Kovalenko S; Rasulev B; Leszczynski J Acta Chim Slov; 2016; 63(3):638-45. PubMed ID: 27640391 [TBL] [Abstract][Full Text] [Related]
16. Molecular modelling, synthesis, cytotoxicity and anti-tumour mechanisms of 2-aryl-6-substituted quinazolinones as dual-targeted anti-cancer agents. Hour MJ; Lee KH; Chen TL; Lee KT; Zhao Y; Lee HZ Br J Pharmacol; 2013 Aug; 169(7):1574-86. PubMed ID: 23638624 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxicity screening of piperazine-1-carbodithioate derivatives of 2-substituted quinazolin-4(3H)-ones. Cao SL; Guo YW; Wang XB; Zhang M; Feng YP; Jiang YY; Wang Y; Gao Q; Ren J Arch Pharm (Weinheim); 2009 Mar; 342(3):182-9. PubMed ID: 19212984 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of tricyclic quinazolinones via intramolecular cyclization of 3-(2-aminoalkyl)-2-(phenylamino)quinazolin-4(3H)-ones. Yang X; Wu M; Sun S; Huang C; Guo H; Wang J; Lee J; Xing Y Mol Divers; 2016 May; 20(2):551-6. PubMed ID: 26470864 [TBL] [Abstract][Full Text] [Related]
19. InCl3-catalysed synthesis of 2-aryl quinazolin-4(3H)-ones and 5-aryl pyrazolo[4,3-d]pyrimidin-7(6H)-ones and their evaluation as potential anticancer agents. Mulakayala N; Kandagatla B; Ismail ; Rapolu RK; Rao P; Mulakayala C; Kumar CS; Iqbal J; Oruganti S Bioorg Med Chem Lett; 2012 Aug; 22(15):5063-6. PubMed ID: 22749421 [TBL] [Abstract][Full Text] [Related]
20. A Novel Mechanistic Study on Ultrasound-Assisted, One-Pot Synthesis of Functionalized Benzimidazo[2,1-b]quinazolin-1(1H)-ones. Chen LH; Chung TW; Narhe BD; Sun CM ACS Comb Sci; 2016 Mar; 18(3):162-9. PubMed ID: 26871300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]